Dr Federica M Marelli-Berg

Publications


Journals

  • Ying H; Fu H; Rose ML; McCormack AM; Sarathchandra P; Okkenhaug K; Marelli-Berg FM. (2012). Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts. PLoS One. 7:e32892. DOI.
  • Marelli-Berg FM; Fu H; Mauro C. (3 Mar 2012). Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T cell-mediated immunity. Immunology. DOI.
  • Ma L; Mauro C; Cornish GH; Chai JG; Coe D; Fu H; Patton D; Okkenhaug K; et alFranzoso G; Dyson J; Nourshargh S; Marelli-Berg FM. (9 Nov 2010). Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance. Proc Natl Acad Sci U S A. 107:19461-19466. DOI.
  • Cernuda-Morollón E; Millán J; Shipman M; Marelli-Berg FM; Ridley AJ. (2010). Rac activation by the T-cell receptor inhibits T cell migration. PLoS One. 5:e12393. DOI.
  • Marelli-Berg FM; Fu H; Vianello F; Tokoyoda K; Hamann A. (Jun 2010). Memory T-cell trafficking: new directions for busy commuters. Immunology. 130:158-165. DOI.
  • Gorman CL; Monaco C; Ammiratti E; Vermi AC; Marelli-Berg FM; Cope AP. (2010). Tracking antigen-experienced effector T cells in vitro and in vivo. Methods Mol Biol. 616:253-267. DOI.
  • Zhu D; Jarmin S; Ribeiro A; Prin F; Xie SQ; Sullivan K; Briscoe J; Gould AP; et alMarelli-Berg FM; Gu Y. (2010). Applying an adaptive watershed to the tissue cell quantification during T-cell migration and embryonic development. Methods Mol Biol. 616:207-228. DOI.
  • Ward SG; Marelli-Berg FM. (15 Feb 2009). Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. BIOCHEMICAL JOURNAL. 418:13-27. Author weblink DOI.
  • David R; Ma L; Ivetic A; Takesono A; Ridley AJ; Chai JG; Tybulewicz VL; Marelli-Berg FM. (16 Apr 2009). T-cell receptor- and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue. Blood. 113:3696-3705. DOI.
  • Dazzi F; Marelli-Berg FM. (1 Jun 2008). Mesenchymal stem cells for graft-versus-host disease: Close encounters with T cells. EUROPEAN JOURNAL OF IMMUNOLOGY. 38:1479-1482. Author weblink DOI.
  • Jarmin SJ; David R; Ma L; Chai J-G; Dewchand H; Takesono A; Ridley AJ; Okkenhaug K; et alMarelli-Berg FM. (1 Mar 2008). T cell receptor-induced phosphoinositide-3-kinase p110 delta activity is required for T cell localization to antigenic tissue in mice. JOURNAL OF CLINICAL INVESTIGATION. 118:1154-1164. Author weblink DOI.
  • Marelli-Berg FM; Cannella L; Dazzi F; Mirenda V. (1 Jan 2008). The highway code of T cell trafficking. JOURNAL OF PATHOLOGY. 214:179-189. Author weblink DOI.
  • David R; Marelli-Berg FM. (1 Nov 2007). Regulation of T-cell migration by co-stimulatory molecules. BIOCHEMICAL SOCIETY TRANSACTIONS. 35:1114-1118. Author weblink.
  • Marelli-Berg FM; Okkenhaug K; Mirenda V. (1 Jun 2007). A two-signal model for T cell trafficking. TRENDS IN IMMUNOLOGY. 28:267-273. Author weblink DOI.
  • Avraamides G; Ng CY; David R; Gu Y; Fazekasova H; Mirenda V; Foster GR; Runkel L; et alLombardi G; Marelli-Berg FM. (Apr 2007). IFN-alpha2 induces leukocyte integrin redistribution, increased adhesion, and migration. J Interferon Cytokine Res. 27:291-303. DOI.
  • Zhang Z; Gorman CL; Vermi AC; Monaco C; Foey A; Owen S; Amjadi P; Vallance A; et alMcClinton C; Marelli-Berg F; Isomäki P; Russell A; Dazzi F; Vyse TJ; Brennan FM; Cope AP. (15 May 2007). TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood. 109:4328-4335. DOI.
  • Mirenda V; Jarmin SJ; David R; Dyson J; Scott D; Gu Y; Lechler RI; Okkenhaug K; et alMarelli-Berg FM. (1 Apr 2007). Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood. 109:2968-2977. DOI.
  • Datta A; David R; Glennie S; Scott D; Cernuda-Morollon E; Lechler RI; Ridley AJ; Marelli-Berg FM. (Dec 2006). Differential effects of immunosuppressive drugs on T-cell motility. Am J Transplant. 6:2871-2883. DOI.
  • Garden OA; Reynolds PR; Yates J; Larkman DJ; Marelli-Berg FM; Haskard DO; Edwards AD; George AJ. (31 Jul 2006). A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferative, regulatory and migratory behaviour in vitro. J Immunol Methods. 314:123-133. DOI.
  • Mason JC; Lidington EA; Rao RM; Marelli-Berg FM; Jat PS; Haskard DO. (8 Mar 2001). Use of H-2Kb-tsA58 transgenic mice to generate conditionally immortalized, growth factor responsive mouse cardiac endothelial cells for in vitro studies. FASEB JOURNAL. 15:A947-A947. Author weblink.
  • Elliott JI; Surprenant A; Marelli-Berg FM; Cooper JC; Cassady-Cain RL; Wooding C; Linton K; Alexander DR; et alHiggins CF. (1 Aug 2005). Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. NATURE CELL BIOLOGY. 7:808-U76. Author weblink DOI.
  • Marelli-Berg FM; Hargreaves RE; Carmichael P; Dorling A; Lombardi G; Lechler RI. (1 Apr 1996). Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med. 183:1603-1612.
  • Lechler RI; Marelli-Berg FM. (May 1997). Do endothelial cells fit the paradigm of antigen-presenting cells?. Biochem Soc Trans. 25:723-727.
  • Lechler R; Marelli-Berg FM. (1997). Mechanisms of peripheral T-cell tolerance. J Viral Hepat. 4 Suppl 2:1-5.
  • Marelli-Berg FM; Weetman A; Frasca L; Deacock SJ; Imami N; Lombardi G; Lechler RI. (15 Dec 1997). Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol. 159:5853-5861.
  • Marelli-Berg FM; Frasca L; Weng L; Lombardi G; Lechler RI. (15 Jan 1999). Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol. 162:696-703.
  • Marelli-Berg FM; Barroso-Herrera O; Lechler RI. (10 Jul 1999). Recently activated T cells are costimulation-dependent in vitro. Cell Immunol. 195:18-27. DOI.
  • Marelli-Berg FM; Frasca L; Imami N; Lombardi G; Lechler RI. (27 Jul 1999). Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cells. Transplantation. 68:280-287.
  • Marelli-Berg FM; Lechler RI. (Dec 1999). Antigen presentation by parenchymal cells: a route to peripheral tolerance?. Immunol Rev. 172:297-314.
  • Foster GR; Masri SH; David R; Jones M; Datta A; Lombardi G; Runkell L; de Dios C; et alSizing I; James MJ; Marelli-Berg FM. (1 Aug 2004). IFN-alpha subtypes differentially affect human T cell motility. J Immunol. 173:1663-1670.
  • Herrera OB; Golshayan D; Tibbott R; Salcido Ochoa F; James MJ; Marelli-Berg FM; Lechler RI. (15 Oct 2004). A novel pathway of alloantigen presentation by dendritic cells. J Immunol. 173:4828-4837.
  • Nourshargh S; Marelli-Berg FM. (Mar 2005). Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol. 26:157-165. DOI.
  • Mirenda V; Millington O; Lechler RI; Scott D; Hernandez-Fuentes MP; Read J; Tan PH; George AJ; et alGarside P; Marelli-Berg FM. (Jul 2005). Tolerant T cells display impaired trafficking ability. Eur J Immunol. 35:2146-2156. DOI.
  • Chandrasekar B; Marelli-Berg FM; Tone M; Bysani S; Prabhu SD; Murray DR. (25 Jun 2004). Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB. Biochem Biophys Res Commun. 319:304-311. DOI.
  • Marelli-Berg FM; Jarmin SJ. (15 May 2004). Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?. Immunol Lett. 93:109-113. DOI.
  • Marelli-Berg FM; James MJ; Dangerfield J; Dyson J; Millrain M; Scott D; Simpson E; Nourshargh S; et alLechler RI. (15 Apr 2004). Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo. Blood. 103:3111-3116. DOI.
  • James MJ; Belaramani L; Prodromidou K; Datta A; Nourshargh S; Lombardi G; Dyson J; Scott D; et alSimpson E; Cardozo L; Warrens A; Szydlo RM; Lechler RI; Marelli-Berg FM. (15 Sep 2003). Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood. 102:2173-2179. DOI.
  • Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS. (14 Feb 2003). Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem. 278:4675-4686. DOI.
  • Berg LP; James MJ; Alvarez-Iglesias M; Glennie S; Lechler RI; Marelli-Berg FM. (1 Apr 2002). Functional consequences of noncognate interactions between CD4+ memory T lymphocytes and the endothelium. J Immunol. 168:3227-3234.
  • Lidington EA; Rao RM; Marelli-Berg FM; Jat PS; Haskard DO; Mason JC. (Jan 2002). Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol. 282:C67-C74.
  • Lechler R; Chai JG; Marelli-Berg F; Lombardi G. (Jul 2001). The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology. 103:262-269.
  • Lechler R; Chai JG; Marelli-Berg F; Lombardi G. (29 May 2001). T-cell anergy and peripheral T-cell tolerance. Philos Trans R Soc Lond B Biol Sci. 356:625-637. DOI.
  • Marelli-Berg FM; Peek E; Lidington EA; Stauss HJ; Lechler RI. (20 Oct 2000). Isolation of endothelial cells from murine tissue. J Immunol Methods. 244:205-215.
  • Marelli-Berg FM; Scott D; Bartok I; Peek E; Dyson J; Lechler RI. (15 Oct 2000). Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation?. J Immunol. 165:4182-4189.
  • Marelli-Berg FM; Scott D; Bartok I; Peek E; Dyson J; Lechler RI. (Feb 2001). Antigen presentation by murine endothelial cells. Transplant Proc. 33:315-316.
  • Marelli-Berg FM; Alvarez-Iglesias M; Prodromidou K; Lombardi G; Frasca L; Berg LP; Lechler RI. (Feb 2001). T cell receptor engagement can influence T cell motility. Transplant Proc. 33:312-313.

Conferences

  • David R; Marelli-Berg FM. Regulation of T-cell migration by co-stimulatory molecules. Focus Topic at Life Sciences 2007 Conference. 35:1114-1118. (Nov 2007).
  • Mirenda V; Jarmin SJ; David R; Dyson J; Scott D; Gu Y; Lechler RI; Okkenhaug K; et alMarelli-Berg FM. Physiological and aberrant regulation of memory T cell trafficking by the co-stimulatory molecule CD28. Annual Congress of the British-Society-of-Immunology. 120:31-31. (Mar 2007).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook